PUBLIC COMPANY
saveFerring Pharmaceuticals Inc
updated 2mo ago
Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.
community read0 votes
🐶 often sniffed alongside
top 2pipeline
9
marketed
9
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(9)
pipeline depth9 products
9Marketed
Marketed
Menopur
Anovulation
Marketedchorionic gonadotropin
Secondary (Hypogonadotropic) Hypogonadism
Marketeddegarelix acetate
Metastatic Prostate Cancer
Marketeddesmopressin acetate
Diabetes Insipidus
Marketeddinoprostone ER
Cervical Ripening In Pregnant Women Near Term
Marketedfecal microbiota, live-jslm
Clostridioides difficile Infections (Clostridium difficil…
Marketedganirelix acetate
Ovarian Hyperstimulation Syndrome
Marketednadofaragene firadenovec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Marketedurofollitropin
Anovulation
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
- phase3A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
- phase2Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
- phase1An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
- phase1An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
- —Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings
- —ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
- phase3A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that